ConductScience.org, home

Paper12480697

SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.

Wang J and 9 others. Blood, 2003. Cited by 177 papers, by iCite.

Cite this record

ConductScience Library. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Papers, record 12480697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12480697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.
PubMed
Journal
Blood
PubMed
Year
2003
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
177
iCite
Relative citation ratio, by iCite
3.05
iCite
Revised in PubMed
2021-02-06
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang JJianfeng
2Kimura TTakafumi
3Asada RRumiko
4Harada SSachio
5Yokota SShouhei
6Kawamoto YYoshio
7Fujimura YYoshihiro
8Tsuji TTakashi
9Ikehara SSusumu
10Sonoda YYoshiaki

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone MarrowMajor topic
Cord Blood Stem Cell TransplantationMajor topic
Hematopoietic Stem CellsMajor topic
Animals
Antigens, CD34
Bone Marrow Transplantation
Cell Lineage
Cell Movement
Cell Separation
Clone Cells
Colony-Forming Units Assay
Graft Survival
Humans
Infant, Newborn
Injections
Lymphocytes
Mice
Mice, Inbred NOD
Mice, SCID
Myeloid Cells
Receptors, CXCR4
Severe Combined Immunodeficiency
Transplantation Chimera
Transplantation, Heterologous

Source PubMed

Download CSV of topics

Cited by67

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 177 citations.

PMIDTitleJournalYearIn PapersSource
42380918The ubiquitin E3 ligase TRIM59 in myeloid cell regulates complement C3 through degrading CCAAT/enhancer binding protein β to promote neuron survival after ischemic stroke.Cell Biosci2026https://conductscience.org/library/papers/42380918PubMed
40002599Distinct Phenotypic and Molecular Characteristics of CD34- and CD34+ Hematopoietic Stem/Progenitor Cell Subsets in Cord Blood and Bone Marrow Samples: Implications for Clinical Applications.Diagnostics (Basel)2025https://conductscience.org/library/papers/40002599PubMed
38322982α1,3-fucosylation treatment improves cord blood CD34 negative hematopoietic stem cell navigation.iScience2024https://conductscience.org/library/papers/38322982PubMed
37511462Thymocyte Development of Humanized Mice Is Promoted by Interactions with Human-Derived Antigen Presenting Cells upon Immunization.Int J Mol Sci2023https://conductscience.org/library/papers/37511462PubMed
35915364Adult Stem Cell Therapy as Regenerative Medicine for End-Stage Liver Disease.Adv Exp Med Biol2022https://conductscience.org/library/papers/35915364PubMed
35581599
Direct bone marrow injection of human bone marrow-derived stromal cells into mouse femurs results in greater prostate cancer PC-3 cell proliferation, but not specifically proliferation within the injected femurs.
BMC Cancer2022https://conductscience.org/library/papers/35581599PubMed
35531956Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment.JCI Insight2022https://conductscience.org/library/papers/35531956PubMed
34910301Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).Eur J Immunol2021https://conductscience.org/library/papers/34910301PubMed
34869042Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research.Front Oncol2021https://conductscience.org/library/papers/34869042PubMed
33845908Human bone marrow-derived stromal cell behavior when injected directly into the bone marrow of NOD-scid-gamma mice pre-conditioned with sub-lethal irradiation.Stem Cell Res Ther2021https://conductscience.org/library/papers/33845908PubMed
33603749Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy.Front Immunol2020https://conductscience.org/library/papers/33603749PubMed
32987729Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor Cells.Cells2020https://conductscience.org/library/papers/32987729PubMed
31697695Capacity of the medullary cavity of tibia and femur for intra-bone marrow transplantation in mice.PLoS One2019https://conductscience.org/library/papers/31697695PubMed
31633216Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).Eur J Immunol2019https://conductscience.org/library/papers/31633216PubMed
30982173One-Year Observation of the SCID-Repopulating Cell Activities of Human Cord Blood-Derived CD34-Positive and -Negative Hematopoietic Stem Cells.Stem Cell Rev Rep2019https://conductscience.org/library/papers/30982173PubMed
30972754Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.Br J Haematol2019https://conductscience.org/library/papers/30972754PubMed
30046987
The number of CD34+CD133+ hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34+ cells: a possible new indicator for quality evaluation of UCB units.
Int J Hematol2018https://conductscience.org/library/papers/30046987PubMed
29875383A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells.Nat Commun2018https://conductscience.org/library/papers/29875383PubMed
29399087Simultaneous harvesting of endothelial progenitor cells and mesenchymal stem cells from the human umbilical cord.Exp Ther Med2018https://conductscience.org/library/papers/29399087PubMed
29296932Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44.Blood Adv2017https://conductscience.org/library/papers/29296932PubMed

See all 67 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CXCL126387PubTator's text mininghttps://conductscience.org/library/genes/6387NCBI Gene
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852NCBI Gene
SRC6714PubTator's text mininghttps://conductscience.org/library/genes/6714NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12480697

GET https://conductscience.org/api/papers/v1/12480697/cited_by?page=2